Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver

American Journal of Pathology

Volumn 163, Issue 6, 2003, Pages 2303-2317

  Seth, Devanshi ^a   Leo, Maria A ^c,d   McGuinness, Peter H ^a   Lieber, Charles S ^c,d   Brennan, Yvonne ^a   Williams, Rohan ^b   Wang, Xin M ^a   McCaughan, Geoffrey W ^a,b   Gorrell, Mark D ^a,b   Haber, Paul S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; COLLAGEN; MATRIX METALLOPROTEINASE; METALLOTHIONEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CELL ACTIVATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA MICROARRAY; FIBRIN FORMATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STELLATE CELL; UNINDEXED SEQUENCE; UPREGULATION; XENOBIOTIC METABOLISM;

EID: 10744227641     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63587-0     Document Type: Article

References (55)

1. Hill DB, Deaciuc IV, Nanji AA, McClain CJ: Mechanisms of hepatic injury in alcoholic liver disease. Clinics in Liver Disease. Edited by N Gitlin, AJ McCullough. Philadelphia, Saunders, 1998, pp 703-721
2. Thurman II RG: Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998, 275:G605-G611
3. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A: Mitochondrial glutathione: importance and transport. Semin Liver Dis 1998, 18:389-401
4. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW: Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 2001, 49:565-576
5. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW: Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002, 160:641-654
6. Lieber CS, DeCarli L, Rubin E: Sequential production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc Natl Acad Sci USA 1975, 72:437-441
7. Seth D, Gorrell MD, McGuinness PH, Leo MA, Lieber CS, McCaughan GW, Haber PS: SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. J Biochem Biophys Methods 2003, 55:53-66
8. Ihaka R, Gentleman RR: "R": a language for data analysis and graphics. J Comput Graph Statist 1996, 5:299-314
9. Yang YH, Dudoit S, Luu P, Speed TP: Normalization for cDNA microarray data. Microarrays: Optical Technologies and Informatics. Proc SPIE (The International Society for Optical Engineering). Edited by Bittner ML, Chen Y, Dorsal AN, Dougherty ER, 2001, pp 141-152
10. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:1-10
11. Bouton CM, Pevsner J: DRAGON View: information visualization for annotated microarray data. Bioinformatics 2002, 18:323-324
12. Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, Putten KV, McCaughan GW, Eris JM, Bishop GA: Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 2001, 79:213-221
13. Shackel NA, Gorrell MD, McCaughan GW: Gene array analysis and the liver. Hepatology 2002, 36:1313-1325
14. Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Rogers J, Handelsman DJ, Dong Q: Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 2001, 61:6331-6334
15. Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Mueller E, Retting WJ, Gorrell MD: Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 1999, 29:1768-1778
16. Ajami K, Abbott CA, Obradovic M, Gysbers V, Kähne T, McCaughan GW, Gorrell MD: Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. Biochemistry 2003, 42:694-701
17. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K: Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001, 120:955-966
18. McCaughan GW, Shackel NA, Gorrell MD: Differential gene expression between chronic hepatitis B and C hepatic lesions (letter). Gastroenterology 2001, 121:1263-1264
19. Deaciuc IV, D'Souza NB, de Villiers WJ, Burikhanov R, Sarphie TG, Hill DB, McClain CJ: Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2001, 25:935-943
20. Zuo GQ, Gong JP, Liu CA, Li SW, Wu XC, Yang K, Li Y: Expression of lipopolysaccharide binding protein and its receptor CD14 in experimental alcoholic liver disease. World J Gastroenterol 2001, 7:836-840
21. Bautista AP: Acute alcohol intoxication and endotoxemia desensitize HIV-1 gp120-induced CC-chemokine production by Kupffer cells. Life Sci 2001, 68:1939-1949
22. Okazaki I, Watanabe T, Hozawa S, Arai M, Maruyama K: Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. J Gastroenterol Hepatol 2000, 15:D26-D32
23. Okazaki I, Watanabe T, Hozawa S, Niioka M, Arai M, Maruyama K: Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J Med 2001, 50:58-65
24. Potter JJ, Rennie-Tankersley L, Mezey E: Endotoxin enhances liver alcohol dehydrogenase by action through upstream stimulatory factor but not by nuclear factor-kappa B. J Biol Chem 2003, 278:4353-4357
25. Dodd PR, Lewohl JM: Cell death mediated by amino acid transmitter receptors in human alcoholic brain damage: conflicts in the evidence. Ann NY Acad Sci 1998, 844:50-58
26. Thomas GJ, Harper CG, Dodd PR: Expression of GABA(A) receptor isoform genes in the cerebral cortex of cirrhotic and alcoholic cases assessed by S1 nuclease protection assays. Neurochem Int 1998, 32:375-385
27. Booyse FM, Aikens ML, Grenett HE: Endothelial cell fibrinolysis: transcriptional regulation of fibrinolytic protein gene expression (t-PA, u-PA, and PAI-1) by low alcohol. Alcohol Clin Exp Res 1999, 23:1119-1124
28. Tsutsumi M, Urashima S, Nakase K, Takase S, Takada A: Type IV collagen and laminin contents of livers from patients with alcoholic liver disease. Alcohol Alcohol Suppl 1993, 1A:45-52
29. Yamada H, Aida T, Taguchi K, Asano G: Expression of type III and IV procollagen, prolyl 4-hydroxylase mRNAs in fibrotic human liver. Nippon Rinsho-Jpn J Clin Med 1993, 51:423-427
30. Lieber CS: Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997, 77:517-544
31. Oneta CM, Lieber CS, Li J, Ruttimann S, Schmid B, Lattmann J, Rosman AS, Seitz HK: Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 2002, 36:47-52
32. Lasker JM, Tsutsumi M, Bloswick BP, Lieber CS: Characterization of benzoflavone (BF)-inducible hamster liver cytochrome P-450 isozyme catalytically similar to cytochrome P-450-ALC. Hepatology 1987, 7:432 (Abstract)
33. Salmela KS, Kessova IG, Tsyrlov IB, Lieber CS: Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. Alcohol Clin Exp Res 1998, 22:2125-2132
34. Kono H, Bradford BU, Yin M, Sulik KK, Koop DR, Peters JM, Gonzalez FJ, McDonald T, Dikalova A, Kadiiska MB, Mason RP, Thurman RG: CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 1999, 277:G1259-G1267
35. Lieber CS: Metabolism of alcohol. Clinics in Liver Disease: Alcoholic Liver Disease. Edited by A McCullough. Philadelphia, WB Saunders Company, 1998, pp 673-702
36. Zhao M, Matter K, Laissue JA, Zimmermann A: Copper/zinc and manganese superoxide dismutases in alcoholic liver disease: immunohistochemical quantitation. Histol Histopathol 1996, 11:899-907
37. Zhou Z, Sun X, James KY: Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Exp Biol Med 2002, 227:214-222
38. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-2250
39. Spitsyn VA, Nafikova A, Spitsyna N, Afanas'eva IS: Genetic predisposition to development of toxic liver cirrhosis caused by alcohol. Genetika 2001, 37:698-707
40. Skrede S, Blomhoff JP, Elgjo K, Gjone E: Serum proteins in diseases of the liver. Scand J Clin Lab Invest 1975, 35:399-406
41. Rahkonen OP, Koskivirta IM, Oksjoki SM, Jokinen E, Vuorio EI: Characterization of the routine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim Biophys Acta 2002, 1577:45-52
42. Arthur MJ, Iredale JP, Mann DA: Tissue inhibitors of metalloiproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 1999, 23:940-943
43. Lu X, Wang B, Xie Y, Liu C, Fu B: Dynamic change and expression of matrix metalloproteinase-2, -9 in alcoholic liver disease in rats. Chung Hua Kan Tsang Ping Tsa Chih 2001, 9:268-270
44. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F: Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol 1986, 123:264-270
45. Dreier R, Schmid KW, Gerke V, Riehemann K: Differential expression of annexins I, II, and IV in human tissues: an immunohistochemical study. Histochem Cell Biol 1998, 110:137-148
46. Ray MB, Mendenhall CL, French SW, Gartside PS: Bile duct changesin alcoholic liver disease. The Veterans Administration Cooperative Study Group. Liver 1993, 13:36-45
47. Gram J, Duscha H, Zurborn KH, Bruhn HD: Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis. Scand J Gastroenterol 1991, 26:1173-1178
48. Hu KQ, Yu AS, Tiyyagura L, Redeker AG, Reynolds TB: Hypeffibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001, 96:1581-1586
49. Tabengwa EM, Abou-Agag LH, Benza RL, Torres JA, Aikens ML, Booyse FM: Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells. Alcohol Clin Exp Res 2000, 24:754-761
50. Abou-Agag LH, Tabengwa EM, Tresnak JA, Wheeler CG, Taylor KB, Booyse FM: Ethanol-induced increased surface-localised fibrinolytic activity in cultured human endothelial cells: kinetic analysis. Alcohol Clin Exp Res 2001, 25:351-361
51. Falcone DJ, Borth W, Khan KMF, Hajjar KA: Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 2001, 97:777-784
52. Arai M, Nakano S, Okuno F, Hirano Y, Sujita K, Kobayashi T, Ishii H, Tsuchiya M: Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease. Hepatology 1989, 9:846-851
53. de Coupade C, Ajuebor MN, Russo-Marie F, Perretti M, Solito E: Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am J Pathol 2001, 159:1435-1443
54. Flower RJ: Lipocortin. Prog Clin Biol Res 1990, 349:11-25
55. Rothwell NJ, Flower R: Lipocortin-1 exhibits novel actions, providing clinical opportunities. Trends Pharmacol Sci 1992, 13:45-46